![PDF) Groningen Frailty Indicator–Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy PDF) Groningen Frailty Indicator–Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy](https://i1.rgstatic.net/publication/364241237_Groningen_Frailty_Indicator-Chinese_GFI-C_for_pre-frailty_and_frailty_assessment_among_older_people_living_in_communities_psychometric_properties_and_diagnostic_accuracy/links/63405c2976e39959d6a7d713/largepreview.png)
PDF) Groningen Frailty Indicator–Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy
![Registered induced earthquakes from the Groningen field since 1995,... | Download Scientific Diagram Registered induced earthquakes from the Groningen field since 1995,... | Download Scientific Diagram](https://www.researchgate.net/publication/322559191/figure/fig4/AS:668394739212288@1536369132031/Registered-induced-earthquakes-from-the-Groningen-field-since-1995-with-a-lower-limit-of.png)
Registered induced earthquakes from the Groningen field since 1995,... | Download Scientific Diagram
![Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/8e654f80-9781-4058-af23-e555669af77c/gr3.jpg)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology
![Natalie ISAKSSON | PostDoc Position | Doctor of Philosophy | University of the Highlands and Islands, Inverness | UHI | Environmental Research Institute (ERI) | Research profile Natalie ISAKSSON | PostDoc Position | Doctor of Philosophy | University of the Highlands and Islands, Inverness | UHI | Environmental Research Institute (ERI) | Research profile](https://i1.rgstatic.net/ii/profile.image/11431281178852525-1691073107435_Q512/Natalie-Isaksson.jpg)
Natalie ISAKSSON | PostDoc Position | Doctor of Philosophy | University of the Highlands and Islands, Inverness | UHI | Environmental Research Institute (ERI) | Research profile
![Je kunt gratis 600 online cursussen volgen van 200 universiteiten in de wereld — hier is de complete lijst Je kunt gratis 600 online cursussen volgen van 200 universiteiten in de wereld — hier is de complete lijst](https://cdn.businessinsider.nl/wp-content/uploads/2017/11/bfacd5e83d983002b634d8e745a924821e88a993.jpg)
Je kunt gratis 600 online cursussen volgen van 200 universiteiten in de wereld — hier is de complete lijst
![Improving the Potential of Mean Force and Nonequilibrium Pulling Simulations by Simultaneous Alchemical Modifications | Journal of Chemical Theory and Computation Improving the Potential of Mean Force and Nonequilibrium Pulling Simulations by Simultaneous Alchemical Modifications | Journal of Chemical Theory and Computation](https://pubs.acs.org/cms/10.1021/acs.jctc.1c01194/asset/images/large/ct1c01194_0011.jpeg)
Improving the Potential of Mean Force and Nonequilibrium Pulling Simulations by Simultaneous Alchemical Modifications | Journal of Chemical Theory and Computation
![Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/062d166a-47ab-4c4f-9bcf-c89312c5687c/gr4.jpg)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study - The Lancet Oncology
![PDF) Groningen Frailty Indicator–Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy PDF) Groningen Frailty Indicator–Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy](https://www.researchgate.net/publication/364241237/figure/fig1/AS:11431281088629090@1665195165075/Confirmatory-factor-analysis-model-of-the-Groningen-Frailty-Indicator-Chinese-version_Q320.jpg)